Cointime

Panacos Pharmaceuticals

company

About

Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.

  • 11 - 50

Highlights

Total Funding Amount
$38.30M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$20M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company’s discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$38.30M
Panacos Pharmaceuticals has raised a total of $38.30M in funding over 2 rounds. Their latest funding was raised on Jun 28, 2007 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 28, 2007 Post-IPO Debt $20M 1 Hercules Capital — Detail
May 18, 2004 Post-IPO Equity $18.30M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Panacos Pharmaceuticals is funded by 3 investors. Hercules Capital and Maryland Department of Business and Economic Development are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt
Maryland Department of Business and Economic Development — Post-IPO Equity
New England Partners — Post-IPO Equity
Cointime
İçerikler
Şirket.